臨床試験イメージング市場：製品・サービス、モダリティ、治療分野、エンドユーザー別-2025-2030年世界予測

臨床試験イメージング市場は、2023年に13億1,000万米ドルと評価され、2024年には13億9,000万米ドルに達すると予測され、CAGR 6.68％で成長し、2030年には20億6,000万米ドルに達すると予測されています。

臨床試験イメージングとは、臨床試験においてMRI、CTスキャン、X線、PETスキャンなどの画像技術を使用し、新しい治療法の有効性と安全性を評価することです。画像の使用は、治療介入の生理学的効果を可視化し、意思決定プロセスで使用できる客観的で定量化可能なデータを提供するために不可欠です。臨床試験におけるイメージングの必要性は、正確で再現可能なデータを提供するその能力から生じる。一方、その応用範囲は、腫瘍学、神経学、心臓学など様々な分野に及び、高度なイメージング技術により、腫瘍の反応、神経学的変化、心臓の健康状態をそれぞれ明らかにすることができます。最終用途の利害関係者は、製薬会社やCRO（医薬品開発業務受託機関）から臨床研究を行う学術機関まで多岐にわたる。市場成長は、画像モダリティの技術的進歩、慢性疾患の有病率の増加、臨床試験件数の急増によって推進されます。さらに、AIを活用した解析や新規画像バイオマーカーの統合は大きなビジネスチャンスとなります。しかし、高度な画像技術に関連する高コスト、規制の複雑さ、多施設臨床における物流の課題が成長の妨げとなる可能性があります。技術革新の機会は、低線量での画像品質の向上、ポータブル画像ソリューションの開発、AI統合によるデータ管理と解析の改善にあります。画像収集と読影プロトコルの最適化に向けた調査により、データの忠実性が向上し、その結果、より確実な試験結果が得られる可能性があります。このような機会があるにもかかわらず、競合によるプレッシャーや、地域によっては最先端技術の導入が遅れていることが、大きな課題となる可能性があります。臨床試験イメージングに進出する企業は、技術開発のための協力的パートナーシップ、統合ソリューションのための学際的チームの構築、市場の可能性を効果的につかむための規制ガイドラインの進化に遅れをとらないことに重点を置くべきです。この市場は、急速な技術革新と厳しいコンプライアンス要求によって特徴づけられる、ダイナミックかつ課題的な市場です。

市場力学：急速に進化する臨床試験イメージング市場の主要市場インサイトを公開

臨床試験イメージング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患とがんの世界の蔓延
  • 高度な画像診断技術の採用による精密医療の重視の高まり
• 市場抑制要因
  • イメージング技術に関連する高コストと熟練者の不足
• 市場機会
  • 人工知能（AI）の統合によるエラーの最小化と効率の最大化
  • 臨床試験イメージング技術拡大のための投資と資金調達の増加
• 市場の課題
  • 臨床試験イメージングにおけるプライバシーと同意をめぐる倫理的懸念

ポーターの5つの力：臨床試験イメージング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、臨床試験イメージング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臨床試験イメージング市場における外部からの影響の把握

外部マクロ環境要因は、臨床試験イメージング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臨床試験イメージング市場における競合情勢の把握

臨床試験イメージング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臨床試験イメージング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臨床試験イメージング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨臨床試験イメージング市場における成功への道筋を描く

臨床試験イメージング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患とがんの罹患率が世界中で増加
    • 高度な画像技術の導入による精密医療への重点が高まっている
  • 抑制要因
    • 画像技術に関連する高コストと熟練した人材の不足
  • 機会
    • エラーを最小限に抑え、効率を最大化するための人工知能（AI）の統合
    • 臨床試験イメージング技術の拡大に向けた投資と資金の増加
  • 課題
    • 臨床試験イメージングにおけるプライバシーと同意に関する倫理的懸念
• 市場セグメンテーション分析
  • 製品とサービス：臨床試験イメージングサービス提供の進歩
  • モダリティ：迅速な画像化能力と詳細な断面画像が得られるため、コンピュータ断層撮影法がますます好まれるようになっている
  • 治療領域：多様な治療領域における臨床試験イメージングの中心的な役割とその進化する応用
  • エンドユーザー：学術機関や政府調査機関における臨床試験イメージングの需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 臨床試験イメージング市場：製品・サービス別

• サービス
  • 運用イメージングサービス
  • 分析サービスを読む
  • システムおよび技術サポートサービス
  • 試験設計およびコンサルティングサービス
• ソフトウェア

第7章 臨床試験イメージング市場：モダリティ別

• コンピュータ断層撮影
• 心エコー検査
• 磁気共鳴画像
• 陽電子放出断層撮影
• 超音波
• X線

第8章 臨床試験イメージング市場治療領域別

• 内分泌学
• 免疫疾患
• 感染症
• 神経学
• 腫瘍学

第9章 臨床試験イメージング市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジー企業
• 契約調査機関
• 製薬会社

第10章 南北アメリカの臨床試験イメージング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の臨床試験イメージング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの臨床試験イメージング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • DeepHealthはHOPPRと提携し、高度なAI画像モデルでがん検出に革命を起こします。
  • Subtle Medicalは、NIHの資金提供を受けたAI技術で脳MRIの効率を高め、臨床画像診断に革命を起こしました。
  • GEヘルスケアの戦略的買収により超音波画像診断の精度におけるAI機能強化
  • VoiantとThironaの戦略的提携により、肺臨床試験におけるAIイメージングに革命を起こす
  • RapidAIの日本進出は臨床試験イメージングイノベーションにおける重要な節目となる
  • Aidocは、医療画像の精度に革命をもたらす包括的なAIモデルの開発に3,000万米ドルを投資
  • AIデジタルツインを活用し、がん臨床試験の設計を変革するアルティスラボの世界イニシアチブ
  • WCGはMint Medicalと提携し、腫瘍学臨床試験における画像ワークフローを革新し、データ精度を向上
  • 臨床試験に革命を起こす：Clarioがリアルタイムデータアクセスのためのクラウドベースの画像ビューアを導入
• 戦略分析と提言
  • クラリオ
  • WCGクリニカル株式会社
  • イキシコPLC
  • アイコンPLC

企業一覧

• Alimentiv Inc.
• Anagram 4 Clinical Trials
• Biospective Inc.
• Boston Imaging Core Lab LLC
• Cardiovascular Imaging Technologies LLC
• Clario
• GE HealthCare Technologies Inc.
• Icon PLC
• Image Core Lab Private Limited
• Imaging Endpoints II LLC
• Ixico PLC
• Median Technologies
• Medical Metrics Inc. by Catalent, Inc.
• Medidata by Dassault Systemes
• Medpace, Inc.
• Micron Inc.
• Perceptive Informatics LLC
• ProScan Imaging LLC
• Resonance Health Ltd.
• Voiant Clinical
• WCG Clinical, Inc.

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL TRIAL IMAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL TRIAL IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 82. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 168. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 169. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 170. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 171. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 188. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 189. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 190. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 191. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 194. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 195. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 196. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 243. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Clinical Trial Imaging Market was valued at USD 1.31 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 6.68%, to USD 2.06 billion by 2030.

Clinical Trial Imaging refers to the use of imaging technology such as MRI, CT scans, X-rays, and PET scans in clinical trials to assess the efficacy and safety of new therapies. The use of imaging is essential for visualizing the physiological effects of therapeutic interventions, providing objective, quantifiable data that can be used in decision-making processes. The necessity of imaging in clinical trials arises from its ability to offer precise and reproducible data, while its applications span various areas, including oncology, neurology, and cardiology, where advanced imaging techniques can reveal tumor response, neurological changes, and cardiac health respectively. End-use stakeholders range from pharmaceutical companies and contract research organizations (CROs) to academic institutions conducting clinical research. Market growth is propelled by technological advancements in imaging modalities, increasing prevalence of chronic diseases, and a surge in the number of clinical trials. Furthermore, AI-driven analysis and the integration of novel imaging biomarkers present significant opportunities. However, high costs associated with advanced imaging technologies, regulatory complexities, and logistical challenges in multicenter trials can hinder growth. Opportunities for innovation lie in enhancing imaging quality at lower doses, developing portable imaging solutions, and improving data management and analysis through AI integration. Research directed towards optimizing image acquisition and interpretation protocols can result in better data fidelity and subsequently, more robust trial outcomes. Despite these opportunities, competitive pressure and the slow adoption of cutting-edge technologies in certain regions can pose significant challenges. Businesses venturing into clinical trial imaging should focus on collaborative partnerships for technology development, building multidisciplinary teams for integrated solutions, and staying abreast of evolving regulatory guidelines to seize market potential effectively. The market is both dynamic and challenging, characterized by rapid technological progress and stringent compliance demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Imaging Market

The Clinical Trial Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic diseases and cancer worldwide
  • Increasing emphasis on precision medicine for the adoption of advanced imaging techniques
• Market Restraints
  • High cost associated with the imaging techniques and shortage of skilled personnel
• Market Opportunities
  • Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
  • Increasing investments and funding for the expansion of clinical trial imaging technology
• Market Challenges
  • Ethical concerns around privacy and consent in clinical trial imaging

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Imaging Market

A detailed market share analysis in the Clinical Trial Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trial Imaging Market

A strategic analysis of the Clinical Trial Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Imaging Market, highlighting leading vendors and their innovative profiles. These include Alimentiv Inc., Anagram 4 Clinical Trials, Biospective Inc., Boston Imaging Core Lab LLC, Cardiovascular Imaging Technologies LLC, Clario, GE HealthCare Technologies Inc., Icon PLC, Image Core Lab Private Limited, Imaging Endpoints II LLC, Ixico PLC, Median Technologies, Medical Metrics Inc. by Catalent, Inc., Medidata by Dassault Systemes, Medpace, Inc., Micron Inc., Perceptive Informatics LLC, ProScan Imaging LLC, Resonance Health Ltd., Voiant Clinical, and WCG Clinical, Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Services and Software. The Services is further studied across Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services.
• Based on Modality, market is studied across Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray.
• Based on Therapeutic area, market is studied across Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology.
• Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases and cancer worldwide
    • 5.1.1.2. Increasing emphasis on precision medicine for the adoption of advanced imaging techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the imaging techniques and shortage of skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
    • 5.1.3.2. Increasing investments and funding for the expansion of clinical trial imaging technology
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns around privacy and consent in clinical trial imaging
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product & Service: Increasing advancements in clinical trial imaging service offerings
  • 5.2.2. Modality: Growing preference for computed tomography for quick imaging capability and detailed cross-sectional views
  • 5.2.3. Therapeutic area: Pivotal role of clinical trial imaging across diverse therapeutic areas and its evolving applications
  • 5.2.4. End-User: Rising demand of clinical trial imaging in academic & government research institutes
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Trial Imaging Market, by Product & Service

• 6.1. Introduction
• 6.2. Services
  • 6.2.1. Operational Imaging Services
  • 6.2.2. Read Analysis Services
  • 6.2.3. System & Technical Support Services
  • 6.2.4. Trial Design & Consulting Services
• 6.3. Software

7. Clinical Trial Imaging Market, by Modality

• 7.1. Introduction
• 7.2. Computed Tomography
• 7.3. Echocardiography
• 7.4. Magnetic Resonance Imaging
• 7.5. Positron Emission Tomography
• 7.6. Ultrasound
• 7.7. X-Ray

8. Clinical Trial Imaging Market, by Therapeutic area

• 8.1. Introduction
• 8.2. Endocrinology
• 8.3. Immunological Disorder
• 8.4. Infectious Diseases
• 8.5. Neurology
• 8.6. Oncology

9. Clinical Trial Imaging Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Government Research Institutes
• 9.3. Biotechnology Companies
• 9.4. Contract Research Organizations
• 9.5. Pharmaceutical Companies

10. Americas Clinical Trial Imaging Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Clinical Trial Imaging Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trial Imaging Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. DeepHealth partners with HOPPR to revolutionize cancer detection with advanced AI imaging models
  • 13.3.2. Subtle Medical revolutionizes clinical imaging with NIH-funded AI tech for enhanced brain MRI efficiency
  • 13.3.3. GE HealthCare's strategic acquisition to enhance AI capabilities in ultrasound imaging precision
  • 13.3.4. Strategic partnership between Voiant and Thirona to revolutionize AI imaging in pulmonary clinical trials
  • 13.3.5. RapidAI's expansion into Japan marks a significant milestone in clinical trial imaging innovation
  • 13.3.6. Aidoc invests USD 30 million to advance comprehensive AI models revolutionizing precision in medical imaging
  • 13.3.7. Altis Labs' global initiative using AI digital twins to transform cancer clinical trial design
  • 13.3.8. WCG partners with Mint Medical to revolutionize imaging workflows in oncology clinical trials for enhanced data precision
  • 13.3.9. Revolutionizing clinical trials: Clario introduces cloud-based image viewer for real-time data access
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. Clario
  • 13.4.2. WCG Clinical, Inc.
  • 13.4.3. Ixico PLC
  • 13.4.4. Icon PLC

Companies Mentioned

• 1. Alimentiv Inc.
• 2. Anagram 4 Clinical Trials
• 3. Biospective Inc.
• 4. Boston Imaging Core Lab LLC
• 5. Cardiovascular Imaging Technologies LLC
• 6. Clario
• 7. GE HealthCare Technologies Inc.
• 8. Icon PLC
• 9. Image Core Lab Private Limited
• 10. Imaging Endpoints II LLC
• 11. Ixico PLC
• 12. Median Technologies
• 13. Medical Metrics Inc. by Catalent, Inc.
• 14. Medidata by Dassault Systemes
• 15. Medpace, Inc.
• 16. Micron Inc.
• 17. Perceptive Informatics LLC
• 18. ProScan Imaging LLC
• 19. Resonance Health Ltd.
• 20. Voiant Clinical
• 21. WCG Clinical, Inc.